Early pulmonary inflammation in infants with cystic fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 151, Issue 4, 1995, Pages 1075-1082

  Khan, Talat Z ^b   Wagener, Jeffrey S ^b   Bost, Thomas ^b   Martinez, Jose ^b   Accurso, Frank J ^b   Riches, David W H ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; CHEMOKINE; INTERLEUKIN 8; LEUKOCYTE ELASTASE; MESSENGER RNA;

ARTICLE; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; ENZYME ACTIVITY; HUMAN; INFANT; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; NEUTROPHIL; PNEUMONIA; PRIORITY JOURNAL;

EID: 0028914085     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm/151.4.1075     Document Type: Article

References (50)

1. Rosenstein, B. J., and T. S. Langbaum. 1984. Diagnosis. In L. M. Taussig, editor. Cystic Fibrosis: Thieme-Stratton, New York. 85-115.
2. Boat, T. F., M. J. Welsh, and A. L. Beaudet. 1989. Cystic fibrosis. In C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, editors. The Metabolic Basis of Inherited Disease. McGraw-Hill, New York. 2649-2680.
3. Wood, R. E., T. F. Boat, and C. F. Doershuk. 1976. Cystic fibrosis. Am. Rev. Respir. Dis. 833-878.
4. Pennington, J. E., S. M. Wolff, and M. Puziss. 1979. Summary of a workshop on infections in patients with cystic fibrosis. J. Infect. Dis. 140: 252-256.
5. Høiby, N. 1982. Microbiology of lung infections in cystic fibrosis patients. Acta. Paediatr. Scand. Suppl. 301:33-54.
6. Meyer, K. C., R. J. Lewandoski, J. J. Zimmerman, D. Nunley, W. J. Calhoun, and G. A. Dopico. 1991. Human neutrophil elastase and elastase/ alpha-1 antiprotease complex in cystic fibrosis. Am. Rev. Respir. Dis. 144: 580-585.
7. Suter, S., U. B. Schaad, H. Tegner, K. Ohlsson, D. Desgrandchamps, and F. A. Waldvogel. 1986. Levels of free granulocyte elastase in bronchial secretions from patients with cystic fibrosis: effect of antimicrobial treatment against Pseudomonas aeruginosa. J. Infect. Dis. 153:902-909.
8. Høiby, N., E. W. Flensborg, B. Beck, B. Friis, S. V. Jacobson, and L. Jacobson. 1976. Pseudomonas aeruginosa infection in cystic fibrosis. Scand. J. Respir. Dis. 58:65-79.
9. Fick, R. B. and H. Y. Reynolds. 1983. Pseudomonas respiratory infection in cystic fibrosis: a possible defect in opsonic IgG antibody? Bull. Eur. Physiopathol. Respir. 19:151-161.
10. Kerum, E., M. Corey, R. Gold, and H. Levison. 1990. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J. Pediatr. 116:714-719.
11. Wood, R. E. 1989. Treatment of CF lung disease in the first two years. Pediatr. Pulmonol. 4(Suppl.):68-70.
12. Wood, R. E., P. Gilligan, and K. C. Blair. 1991. Microbiology of the lower respiratory tract in infants with cystic fibrosis. Pediatr. Pulmonol. 6(Suppl.) Abstract 213:281.
13. Wilmott, R. W., J. T. Kassab, P. L. Kilian, W. R. Benjamin, S. D. Douglas, and R. E. Wood. 1990. Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections. Am. Rev. Respir. Dis. 142:365-368.
14. Hammond, K. B., S. H. Abman, R. J. Sokol, and F. J. Accurso. 1991. Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations. N. Engl. J. Med. 325:769-774.
15. Baggiolini, M., A. Walz, and S. L. Kunkel. 1989. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest. 84:1045-1049.
16. Richman-Eisenstat, J. B. Y., P. G. Jorens, C. A. Hebert, I. Ueki, and J. A. Nadel. 1993. Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway disease. Am. J. Physiol. 264: L413-L418.
17. Dean, T. P., Y. Dai, J. K. Shute, M. K. Church, and J. O. Warner. 1993. Interleukin-8 concentrations are elevated in bronchoalveolar lavage, sputum and sera of children with cystic fibrosis. Pediatr. Res. 34:159-161.
18. Accurso, F. J., R. J. Sokol, K. B. Hammond, and S. H. Abman. 1991. Early respiratory course in infants with cystic fibrosis: relevance to newborn screening. Pediatr. Pulmonol. (Suppl.) 7:42-45.
19. Hamill, P. V. V., T. A. Drizd, C. L. Johnson, R. B. Reed, A. F. Roche, and W. M. Moore. 1979. Physical growth: National Center for Health Statistics percentiles. Am. J. Clin. Nutr. 32:607-629.
20. Weatherly, M. R., C. G. S. Palmer, M. E. Peters, C. G. Green, D. Fryback, R. Langhough, and P. M. Farrell. 1993. Wisconsin cystic fibrosis chest radiograph scoring system. Pediatrics 91:488-495.
21. Cole, P. J. and R. Wilson. 1989. Host-microbial interrelationships in respiratory infections. Chest 95:217S-221S.
22. Abman, S. H., J. W. Ogle, R. J. Harbeck, N. Butler-Simon, K. B. Hammond, and F. J. Accurso. 1991. Early bacteriologic, immunologic and clinical courses of young infants with cystic fibrosis identified by neonatal screening. J. Pediatr. 119:211-217.
23. Cohen, J. and J. S. McConnell. 1984. Observations on the measurement and evaluation of endotoxemia by quantitative Limulus lysate microassay. J. Infect. Dis. 150:916-924.
24. Carre, P. C., R. L. Mortenson, T. E. J. King, P. W. Noble, C. Sable, and D. W. H. Riches. 1991. Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. A potential mechanism for the recruitment and activation of neutrophils in lung fibrosis. J. Clin. Invest. 88:1802-1810.
25. Sporn, S. A., D. F. Eierman, C. E. Johnson, J. Morris, G. Martin, M. Ladner, and S. Haskill. 1990. Monocyte adherence results in selective induction of novel genes sharing homology with mediators of inflammation and tissue repair. J. Immunol. 144:4434-4441.
26. Krug, M. S. and S. L. Berger. 1987. First strand cDNA synthesis primed with oligo-(dT). Methods Enzymol. 152:316-325.
27. Clement, A., K. Chadelat, J. Masliah, B. Housset, A. Sardet, A. Grimfield, and G. Tournier. 1987. A controlled study of oxygen metabolite release by alveolar macrophages from children with interstitial lung disease. Am. Rev. Respir. Dis. 136:1424-1428.
28. Ferguson, A. C., and F. W. Wong. 1992. Experience with flexible fiberoptic bronchoscopy with bronchoalveolar lavage as a diagnostic tool in children with AIDS. Am. J. Dis. Child. 146:1056-1059.
29. Rennard, S. I., G. Basset, D. Lecossier, K. M. O'Donnell, P. Pinkston, P. G. Martin, and R. G. Crystal. 1986. Estimation of volume of epithelial lining fluid recovered by lavage using urea as a marker of dilution. J. Appl. Physiol. 60:532-538.
30. BAL Cooperative Group Steering Committee. 1990. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis and selected comparison groups. Am. Rev. Respir. Dis. 141 :S169-S202.
31. Rommens, J. M., M. C. Iannuzzi, B.-S. Kerem, M. L. Drum, G. Melmer, M. Dean, R. Rozmahel, J. L. Cole, D. Kennedy, N. Hidaka, M. Zsiga, M. Buchwald, J. R. Riodan, L.-C. Tsui, and F. S. Collins. 1989. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245:1059-1065.
32. Lloyd-Still, J. D., K.-T. Khaw, and H. Shwachman. 1974. Severe respiratory disease in infants with cystic fibrosis. Pediatrics 53:678-682.
33. Abman, S. H., J. W. Ogle, N. Butler-Simon, C. M. Rumack, and F. J. Accurso. 1988. Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis. J. Pediatr. 113:826-830.
34. Dankert-Roelse, J. E., G. J. Meerman te, A. Martijn, L. P. Kate ten, and K. Knol. 1989. Survival and clinical outcome in patients with cystic fibrosis, with or without neonatal screening. J. Pediatr. 114:362-367.
35. Smith, A. L., B. Ramsey, G. Redding, and J. Haas. 1989. Endobronchial infection in cystic fibrosis. Acta. Paediatr. Scand. 363:31-36.
36. Zach, M. S. 1990. Lung disease in cystic fibrosis: an updated concept. Pediatr. Pulmonol. 8:188-202.
37. McElvaney, N. G., R. C. Hubbard, P. Birrer, J. Blow, J. Bloggs, and J. Doe. 1991. Aerosol alpha-1-antitypsin treatment for cystic fibrosis. Lancet 337:392-394.
38. Gadek, J. E., G. A. Fells, R. L. Zimmerman, S. I. Rennard, and R. G. Crystal. 1981. Antielastases of human alveolar structures. Implications for protease- antiprotease theory of emphysema. J. Clin. Invest. 68:889-898.
39. Suter, S., U. B. Schaad, L. Roux, U. E. Nydeggerm, and F. A. Waldvogel. 1984. Granulocyte neural proteases and Pseudomonas elastase as possible causes of airway damage in patients with cystic fibrosis. J. Infect. Dis. 149:523-531.
40. Birrer, P., N. G. McElvaney, A. Rudeberg, C. Wirz Sommer, S. Liechti-Gallati, R. Kraemer, R. Hubbard, and R. G. Crystal. 1994. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 150:207-213.
41. Amitani, R., R. Wilson, A. Rutman, R. Reed, C. Ward, D. Burnett, R. A. Stockley, and P. J. Cole. 1991. Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium. Am. J. Respir. Cell. Mol. Biol. 4:26-32.
42. Lungarella, G., and L. Fonzi. 1980. Ultrastructural evidence of mucociliary function impairment induced by elastase. Bull. Eur. Physiopathol. Respir. (16 Suppl): 167-172.
43. Cole, P. J. 1984. A new look at the pathogenesis and management of persistent bronchial sepsis: a "vicious circle" hypothesis and its logical therapeutic connotations. In R. J. Davis, editor. Strategies for the Management of Chronic Bronchial Sepsis. The Medicine Publishing Foundation, Oxford, UK. 1-20.
44. Donnelly, S. C., R. M. Strieter, S. L. Kunkel, A. Walz, C. R. Robertson, D. C. Carter, I. S. Grant, A. J. Pollok, and C. Haslett. 1993. Interleukin-8 and development of adult respiratory distress syndrome in at risk patient groups. Lancet 341:643-647.
45. Myers, M. G., F. P. Koontz, and M. Weinberger. 1983. Lower respiratory infections in patients with cystic fibrosis. In J.D. Lloyd-Still, editor. Cystic Fibrosis. John Wright, Boston, MA.
46. Yoshimura, K., H. Nakamura, B. C. Trapnell, C.-S. Chu, W. Dalemans, A. Pavirani, J.-P. Lecocq, and R. G. Crystal. 1991. Expression of the cystic fibrosis transmembrane conductance regulator gene in cells of non-epithelial origin. Nucl. Acids Res. 19:5417-5423.
47. Knowles, M. R., N. L. Church, W. E. Waltner, J. R. Yankawskas, P. Gilligan, M. King. L. J. Edwards, R. W. Helms, and R. C. Boucher. 1990. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. N. Engl. J. Med. 322:1189-1194.
48. Hubbard, R. C., N. G. McElvaney, P. Birrer, S. Shak, W. W. Robinson, C. Jolley, M. Wu, M. S. Chernick, and R. G. Crystal. 1992. A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis. N. Engl. J. Med. 326:812-815.
49. Aitken, M. L., W. Burke, G. McDonald, S. Shak, A. B. Montgomery, and A. Smith. 1992. Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study. JAMA 267: 1947-1951.
50. Vogelmeier, C., R. Buhl, R. F. Hoyt, E. Wilson, G. A. Fells, R. C. Hubbard, H. P. Schrebli, R. C. Thompson, and R. G. Crystal. 1989. Aerosilization of SLPI to augment antineutrophil elastase protection of pulmonary epithelium. J. Appl. Physiol. 69:1843-1848.